{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:20:37Z","timestamp":1790713237750,"version":"4.1.0"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1097\/mpa.0b013e3181ebb56f","type":"journal-article","created":{"date-parts":[[2010,7,21]],"date-time":"2010-07-21T07:10:36Z","timestamp":1279696236000},"page":"799-800","source":"Crossref","is-referenced-by-count":291,"title":["The NANETS Consensus Guidelines for the Diagnosis and Management of Poorly Differentiated (High-Grade) Extrapulmonary Neuroendocrine Carcinomas"],"prefix":"10.1097","volume":"39","author":[{"given":"Jonathan R.","family":"Strosberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Coppola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Klimstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandria T.","family":"Phan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew H.","family":"Kulke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Wiseman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry K.","family":"Kvols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"5","key":"R1-9-20210212","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/PAS.0b013e318159371c","article-title":"Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?","volume":"32","author":"Shia","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"R2-9-20210212","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s002689900021","article-title":"Pathology and nomenclature of human gastrointestinal neuroendocrine (carcinoid) tumors and related lesions.","volume":"20","author":"Kloppel","year":"1996","journal-title":"World J Surg"},{"issue":"6","key":"R3-9-20210212","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/BF00199342","article-title":"Revised classification of neuroendocrine tumours of the lung, pancreas and gut.","volume":"425","author":"Capella","year":"1995","journal-title":"Virchows Arch"},{"issue":"9","key":"R4-9-20210212","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.humpath.2009.01.010","article-title":"Correlation between grade and prognosis in metastatic gastroenteropancreatic neuroendocrine tumors.","volume":"40","author":"Strosberg","year":"2009","journal-title":"Hum Pathol"},{"issue":"3","key":"R6-9-20210212","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ctrv.2008.10.007","article-title":"Clinical and therapeutic aspects of extrapulmonary small cell carcinoma.","volume":"35","author":"Walenkamp","year":"2009","journal-title":"Cancer Treat Rev"},{"issue":"18","key":"R7-9-20210212","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One hundred years after \"carcinoid\": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.","volume":"26","author":"Yao","year":"2008","journal-title":"J Clin Oncol"},{"issue":"2","key":"R8-9-20210212","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/1097-0142(19910715)68:2<227::AID-CNCR2820680202>3.0.CO;2-I","article-title":"Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms.","volume":"68","author":"Moertel","year":"1991","journal-title":"Cancer"},{"issue":"8","key":"R9-9-20210212","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/sj.bjc.6690325","article-title":"Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin.","volume":"81","author":"Mitry","year":"1999","journal-title":"Br J Cancer"},{"issue":"4","key":"R10-9-20210212","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/oxfordjournals.annonc.a010603","article-title":"Superiority of cisplatin or carboplatin in combination with teniposide and vincristine in the induction chemotherapy of small-cell lung cancer. A randomized trial with 5 years follow up.","volume":"7","author":"Lassen","year":"1996","journal-title":"Ann Oncol"},{"issue":"13","key":"R11-9-20210212","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1200\/JCO.2005.04.8595","article-title":"Randomized phase III trial comparing irinotecan\/cisplatin with etoposide\/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer.","volume":"24","author":"Hanna","year":"2006","journal-title":"J Clin Oncol"},{"issue":"34","key":"R12-9-20210212","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.1200\/JCO.2006.06.5821","article-title":"Phase III trial comparing supportive care alone with supportive care with oral topotecan in patients with relapsed small-cell lung cancer.","volume":"24","author":"O'Brien","year":"2006","journal-title":"J Clin Oncol"},{"issue":"8","key":"R13-9-20210212","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8<1366::AID-CNCR2>3.0.CO;2-D","article-title":"Primary small cell carcinoma of the esophagus: a review of the literature with emphasis on therapy and prognosis.","volume":"80","author":"Casas","year":"1997","journal-title":"Cancer"},{"issue":"9","key":"R14-9-20210212","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/sj.bjc.6601758","article-title":"Small-cell carcinoma of the gastrointestinal tract: a retrospective study of 64 cases.","volume":"90","author":"Brenner","year":"2004","journal-title":"Br J Cancer"},{"issue":"14","key":"R15-9-20210212","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1200\/JCO.2002.12.071","article-title":"Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104.","volume":"20","author":"Takada","year":"2002","journal-title":"J Clin Oncol"},{"key":"R16-9-20210212","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2407-1-5","article-title":"Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis.","volume":"1","author":"Meert","year":"2001","journal-title":"BMC Cancer"},{"issue":"5","key":"R17-9-20210212","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/cncr.22887","article-title":"Extrapulmonary small-cell carcinoma compared with small-cell lung carcinoma: a retrospective single-center study.","volume":"110","author":"Cicin","year":"2007","journal-title":"Cancer"}],"container-title":["Pancreas"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00006676-201008000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T02:10:29Z","timestamp":1618020629000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006676-201008000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/mpa.0b013e3181ebb56f","relation":{},"ISSN":["0885-3177"],"issn-type":[{"value":"0885-3177","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}